Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis

The aim of this study is to analyse survival and prognostic factors in patients diagnosed with squamous cell carcinoma (SCC) presenting a first episode of cancer-associated hypercalcaemia (CAH). Retrospectively, the authors reviewed data from 220 patients with biopsy proven SCC who presented a first episode of CAH. They were treated in a single centre between 1995 and 2007. The survival analyses were done using the Kaplan–Meier method and Cox analysis. The primary endpoint was the overall survival from the date of hypercalcaemia episode. Median age was 55 years. Median survival was 64 days (1–197). Three independent prognostic factors were identified: brain metastasis (hazard ratio (HR) = 2.58 CI (1.03–6.45)), corrected calcaemia > 3 mmol/l (HR = 1.45 CI (1.05–2.01)) and hypoalbuminaemia (HR = 1.48 CI (1.07–2.04)). Using these factors, the authors performed a bedside prognostic score. In conclusion, median survival in patients diagnosed with SCC and CAH is extremely poor. The bedside prognostic score that the authors developed can help to anticipate patients’ prognosis and adapt the treatment. This score needs to be validated on an independent cohort.